Literature DB >> 16675598

The effect of overexpression of Pdx1 and Foxa2 on the differentiation of human embryonic stem cells into pancreatic cells.

Neta Lavon1, Ofra Yanuka, Nissim Benvenisty.   

Abstract

Human embryonic stem cells (HESCs) are pluripotent cells that may serve as a source of cells for transplantation medicine and as a tool to study human embryogenesis. Using genetic manipulation methodologies, we have investigated the potential of HESCs to differentiate into the various pancreatic cell types. We initially created various HESCs carrying the enhanced green fluorescent protein (eGFP) reporter gene under the control of either the insulin promoter or the pancreatic and duodenal homeobox factor-1 (Pdx1) promoter. Our analysis revealed that during the differentiation of HESCs into embryoid bodies (EBs), we could detect green fluorescent cells when eGFP is regulated by Pdx1 promoter but not by insulin promoter. To examine whether we can induce differentiation into pancreatic cells, we have established human embryonic stem cell lines that constitutively express either Pdx1 or the endodermal transcription factor Foxa2. Following differentiation into EBs, the constitutive expression of Pdx1 enhanced the differentiation of HESCs toward pancreatic endocrine and exocrine cell types. Thus, we have demonstrated expression of several transcription factors that are downstream of Pdx1 and various molecular markers for the different pancreatic cell types. However, the expression of the insulin gene could be demonstrated only when the cells differentiated in vivo into teratomas. We conclude that although overexpression of Pdx1 enhanced expression of pancreatic enriched genes, induction of insulin expression may require additional signals that are only present in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16675598     DOI: 10.1634/stemcells.2005-0397

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  26 in total

Review 1.  Vascular potential of human pluripotent stem cells.

Authors:  Ionela Iacobas; Archana Vats; Karen K Hirschi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-07       Impact factor: 8.311

Review 2.  Genetic modification of human embryonic stem cells.

Authors:  Xiaofeng Xia; Su-Chun Zhang
Journal:  Biotechnol Genet Eng Rev       Date:  2007

Review 3.  Genetic modification of stem cells for transplantation.

Authors:  M Ian Phillips; Yao Liang Tang
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

4.  Derivation of genetically modified human pluripotent stem cells with integrated transgenes at unique mapped genomic sites.

Authors:  Eirini P Papapetrou; Michel Sadelain
Journal:  Nat Protoc       Date:  2011-08-04       Impact factor: 13.491

Review 5.  The use of β-cell transcription factors in engineering artificial β cells from non-pancreatic tissue.

Authors:  D Gerace; R Martiniello-Wilks; B A O'Brien; A M Simpson
Journal:  Gene Ther       Date:  2014-10-23       Impact factor: 5.250

Review 6.  Advances and challenges in the differentiation of pluripotent stem cells into pancreatic β cells.

Authors:  Essam M Abdelalim; Mohamed M Emara
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

Review 7.  The potential of stem cells for the restoration of auditory function in humans.

Authors:  Zhengqing Hu; Mats Ulfendahl
Journal:  Regen Med       Date:  2013-05       Impact factor: 3.806

Review 8.  Differentiation into Endoderm Lineage: Pancreatic differentiation from Embryonic Stem Cells.

Authors:  Dong Hyeon Lee; Hyung Min Chung
Journal:  Int J Stem Cells       Date:  2011-06       Impact factor: 2.500

Review 9.  Engineering tissue from human embryonic stem cells.

Authors:  C M Metallo; S M Azarin; L Ji; J J de Pablo; S P Palecek
Journal:  J Cell Mol Med       Date:  2008-01-11       Impact factor: 5.310

10.  In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductase.

Authors:  J L Gori; X Tian; D Swanson; R Gunther; L D Shultz; R S McIvor; D S Kaufman
Journal:  Gene Ther       Date:  2009-10-15       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.